felodipine has been researched along with Bone Diseases, Metabolic in 1 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
Excerpt | Relevance | Reference |
---|---|---|
"Postmenopausal osteoporosis is one of the most common types of osteoporosis resulting from estrogen deficiency in elderly women." | 1.56 | Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway. ( Huo, S; Li, H; Nie, B; Qu, X; Tang, H; Yue, B; Zhang, S, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, S | 1 |
Li, H | 1 |
Tang, H | 1 |
Huo, S | 1 |
Nie, B | 1 |
Qu, X | 1 |
Yue, B | 1 |
1 other study available for felodipine and Bone Diseases, Metabolic
Article | Year |
---|---|
Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Differentiation; Disease Models, Animal; Es | 2020 |